scholarly journals Gynecologic Imaging with a Use of MRI (Diagnostic Imaging Series for Dairy Clinical Practice : Gynecology)

2003 ◽  
Vol 59 (8) ◽  
pp. 895-903
Author(s):  
KAORI TOGASHI
2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Akira Takahashi ◽  
Chieko Sugawara ◽  
Takaharu Kudoh ◽  
Daisuke Uchida ◽  
Tetsuya Tamatani ◽  
...  

Aim.Tonsilloliths are calcified structures that develop in tonsillar crypts. They are commonly detected in daily clinical practice. The prevalence of tonsilloliths was 16 to 24% in previous reports, but it is inconsistent with clinical experience. The aim of this study is to clarify the prevalence, number, and size distribution of tonsilloliths using computed tomography (CT) in a relatively large number of patients.Materials and Methods.We retrospectively reviewed the scans of 2,873 patients referred for CT examinations with regard to tonsilloliths.Results.Palatine tonsilloliths were found in 1,145 out of 2,873 patients (39.9%). The prevalence of tonsilloliths increased with age, and most commonly in patients of ages 50–69. The prevalence in the 30s and younger was statistically lower than in the 40s and older (P< 0.05). The number of tonsilloliths per palatine tonsil ranged from one to 18. The size of the tonsilloliths ranged from 1 to 10 mm. For the patients with multiple CT examinations, the number of tonsilloliths increased in 51 (3.9%) and decreased in 84 (6.5%) of the tonsils.Conclusions.As palatine tonsilloliths are common conditions, screenings for tonsilloliths during the diagnosis of soft tissue calcifications should be included in routine diagnostic imaging.


2020 ◽  
Vol 7 (1) ◽  
pp. 559-587
Author(s):  
Sourabh Shukla ◽  
He Hu ◽  
Hui Cai ◽  
Soo-Khim Chan ◽  
Christine E. Boone ◽  
...  

Viral nanotechnology exploits the prefabricated nanostructures of viruses, which are already abundant in nature. With well-defined molecular architectures, viral nanocarriers offer unprecedented opportunities for precise structural and functional manipulation using genetic engineering and/or bio-orthogonal chemistries. In this manner, they can be loaded with diverse molecular payloads for targeted delivery. Mammalian viruses are already established in the clinic for gene therapy and immunotherapy, and inactivated viruses or virus-like particles have long been used as vaccines. More recently, plant viruses and bacteriophages have been developed as nanocarriers for diagnostic imaging, vaccine and drug delivery, and combined diagnosis/therapy (theranostics). The first wave of these novel virus-based tools has completed clinical development and is poised to make an impact on clinical practice.


Sign in / Sign up

Export Citation Format

Share Document